The following is a summary of "Adherence and persistence among people with type 2 diabetes newly initiating oral semaglutide ...

Alogliptin (NESINA), a dipeptidyl peptidase IV (DPP-4) inhibitor, was approved by the FDA on January 25, 2013 to improve blood sugar control in adults with type 2 diabetes. This drug had been ...

Democratic Progressive Party (DPP) Legislator-at-large Hung Sun-han (洪申翰) has been chosen to succeed Ho Pei-shan (何佩珊) as ...

Major standardization associations and initiatives are partnering to create the best of breed system architecture to support ...

For patients with nephrolithiasis, sodium-glucose cotransporter-2 (SGLT-2) inhibitor use is associated with a reducti ...

President William Ruto on Thursday fired a warning to investigative agencies including the Director of Public Prosecutions ...

For patients with type 2 diabetes mellitus (T2DM), glucagon-like peptide 1 receptor agonist (GLP-1 RA) use is associated with a lower risk for venous thromboembolism (VTE).

SGLT2 inhibitors may help reduce the risk of nephrolithiasis in patients with type 2 diabetes, including those with co-existing gout. Recent large-scale studies support that sodium-glucose ...

In the proportional representation part of the election, the DPP received 11.3 percent of all votes cast, more than double the 4.5 percent it gained in the previous 2021 Lower House election ...

Japan's ruling coalition on Wednesday agreed with a key opposition party on the draft of an economic stimulus package, ...